Company news

Heartseed, Inc. news

Latest news releases, newest first.

View company

Notice Regarding the First Patient Dosed in the Ischemic Heart Disease Cohort in the Phase I/II company-sponsored Clinical Trial of HS-005

October 27, 2026

Notice on Resignation of Independent Board Director

September 17, 2026

Non-consolidated Financial Results for the Six Months Ended June 30, 2026 (Under Japanese GAAP)

August 14, 2026

Notice Regarding the First Patient Dosed in the Phase I/II company-sponsored Clinical Trial of HS-005 (Catheter Administration) for Cardiac Remuscular

June 12, 2026

Decks